title: Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance.
abstract: Increasing levels of paediatric community-acquired pneumonia (CAP), caused by drug-resistant bacteria and antimicrobial resistance, vary with age and countries and, in some cases, serotypes. When empirical first-line treatment administration fails, paediatricians should consider second-line treatments based on the prevalence of local resistance. A more judicious use of antimicrobial agents is also required.
  
  
  CONCLUSIONS
  Knowledge of local epidemiology and an appropriate use of antimicrobial drugs are necessary to treat CAP in this era of antimicrobial resistance.
authors: Department of Health Sciences, University of Florence, Anna Meyer Children's University-Hospital, Florence, Italy.
authors: L
authors: L
authors: Galli
authors: C
authors: C
authors: Montagnani
authors: E
authors: E
authors: Chiappini
authors: M
authors: M
authors: de Martino
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus; D008826:Microbial Sensitivity Tests; D009177:Mycoplasma pneumoniae; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D013296:Streptococcus pneumoniae
chemical_list: D000900:Anti-Bacterial Agents
keywords: Antimicrobial resistance; Children; Community-acquired pneumonia; Drug-resistant bacteria; Paediatricians